Fang Wei Selected Research

MicroRNAs (MicroRNA)

1/2023	Integrative Transcriptome, miRNAs, Degradome, and Phytohormone Analysis of Brassica rapa L. in Response to Plasmodiophora brassicae.
12/2020	EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1.
1/2020	Ampelopsin alleviates sevoflurane-induced cognitive dysfunction by mediating NF-κB pathway in aged rats.
1/2020	Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis.
12/2019	miR‑593 inhibits proliferation and invasion and promotes apoptosis in non‑small cell lung cancer cells by targeting SLUG‑associated signaling pathways.
1/2016	Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103.
3/2014	Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fang Wei Research Topics

Disease

95	Neoplasms (Cancer) 02/2024 - 01/2002
20	Infections 01/2023 - 07/2007
15	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2010
14	Inflammation (Inflammations) 04/2024 - 10/2016
10	Carcinogenesis 03/2023 - 09/2002
9	Stomach Neoplasms (Stomach Cancer) 12/2023 - 01/2013
9	Lung Neoplasms (Lung Cancer) 11/2023 - 08/2007
9	Arthritis (Polyarthritis) 11/2023 - 02/2015
8	Nasopharyngeal Carcinoma 02/2024 - 01/2013
8	Rheumatoid Arthritis 12/2023 - 02/2015
7	Experimental Arthritis 12/2023 - 07/2018
7	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 10/2017
6	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2024 - 01/2015
6	Hypoxia (Hypoxemia) 10/2023 - 06/2014
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2020 - 05/2010
5	COVID-19 12/2023 - 04/2020
5	Myocardial Infarction 12/2023 - 08/2018
4	Breast Neoplasms (Breast Cancer) 01/2024 - 12/2011
4	Fibrosis (Cirrhosis) 11/2023 - 01/2015
4	Adenocarcinoma 10/2023 - 01/2019
4	Body Weight (Weight, Body) 08/2022 - 04/2019
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2017 - 01/2002
3	Carcinoma (Carcinomatosis) 11/2023 - 09/2002
3	Hyperglycemia 06/2023 - 12/2022
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2023 - 12/2013
3	Virus Diseases (Viral Diseases) 12/2021 - 01/2013
3	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2019
3	Atherosclerosis 01/2021 - 10/2018
3	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2020 - 11/2014
3	Hepatocellular Carcinoma (Hepatoma) 03/2019 - 03/2015
3	Glioblastoma (Glioblastoma Multiforme) 12/2018 - 05/2012
3	Primary Effusion Lymphoma 01/2016 - 06/2014
2	Hyperthermia 02/2024 - 01/2013
2	Polyploidy 02/2024 - 01/2021
2	Choroidal Neovascularization 01/2024 - 09/2021
2	Macular Degeneration (Age-Related Maculopathy) 01/2024 - 09/2021
2	Wounds and Injuries (Trauma) 11/2023 - 06/2023
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2023 - 01/2022
2	Non-alcoholic Fatty Liver Disease 10/2023 - 01/2020

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2002
16	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2009
15	Long Noncoding RNAIBA 04/2024 - 01/2016
11	CytokinesIBA 01/2021 - 12/2013
10	Messenger RNA (mRNA)IBA 04/2024 - 09/2002
8	Circulating Tumor DNAIBA 06/2023 - 01/2015
8	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 07/2007
7	EnzymesIBA 02/2024 - 08/2007
7	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2017
7	MicroRNAs (MicroRNA)IBA 01/2023 - 03/2014
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 09/2010
5	BerberineIBA 12/2023 - 06/2019
5	Cell-Free Nucleic AcidsIBA 11/2023 - 07/2023
5	ErbB Receptors (EGF Receptor)IBA 07/2020 - 11/2014
5	LuciferasesIBA 01/2018 - 07/2007
4	RNA (Ribonucleic Acid)IBA 02/2024 - 11/2019
4	AntigensIBA 12/2023 - 01/2020
4	Circular RNAIBA 12/2023 - 01/2018
4	Retinaldehyde (Retinal)IBA 06/2023 - 09/2017
4	Deoxyglucose (2 Deoxy D glucose)IBA 01/2023 - 07/2018
4	Anaplastic Lymphoma KinaseIBA 01/2023 - 12/2013
4	Peptides (Polypeptides)IBA 11/2020 - 01/2017
4	Small Interfering RNA (siRNA)IBA 11/2020 - 09/2010
4	InterferonsIBA 01/2017 - 01/2014
3	Protein Isoforms (Isoforms)IBA 04/2024 - 09/2002
3	ImmunosorbentsIBA 12/2023 - 02/2008
3	Mechanistic Target of Rapamycin Complex 1IBA 11/2023 - 12/2013
3	Oxygen (Dioxygen)IBA 10/2023 - 10/2016
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023 - 12/2013
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2023 - 01/2018
3	SaltsIBA 01/2023 - 01/2022
3	VaccinesIBA 01/2023 - 11/2004
3	Immune Checkpoint InhibitorsIBA 01/2023 - 12/2022
3	Interleukin-6 (Interleukin 6)IBA 08/2022 - 01/2017
3	Vitamin D FDA LinkGeneric 05/2022 - 07/2018
3	EpitopesIBA 01/2022 - 11/2004
3	Air Pollutants (Pollutants, Air)IBA 03/2021 - 03/2020
3	Interleukin-10 (Interleukin 10)IBA 06/2019 - 12/2013
3	InterleukinsIBA 06/2019 - 07/2009
3	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2014
3	Fluorescein (Funduscein)FDA LinkGeneric 12/2018 - 04/2014
3	isothiocyanic acidIBA 12/2018 - 04/2014
3	Fluorescein-5-isothiocyanate (FITC)IBA 12/2018 - 04/2014
3	Interleukin-12 (IL 12)IBA 01/2017 - 01/2013
3	ProdrugsIBA 08/2010 - 08/2007
3	ginatonIBA 04/2010 - 04/2006
2	Phosphotransferases (Kinase)IBA 02/2024 - 01/2013
2	Hyaluronic Acid (Hyaluronan)IBA 01/2024 - 11/2023
2	Neutralizing AntibodiesIBA 12/2023 - 07/2018
2	AMP-Activated Protein KinasesIBA 11/2023 - 10/2020
2	ProstaglandinsIBA 10/2023 - 08/2019
2	AcidsIBA 10/2023 - 07/2016
2	leonurineIBA 03/2023 - 08/2018

Therapy/Procedure

37	Therapeutics 02/2024 - 08/2009
9	Immunotherapy 01/2024 - 03/2015
7	Catheters 07/2021 - 07/2015
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
4	Renal Dialysis (Hemodialysis) 07/2021 - 10/2015
3	Radiotherapy 02/2024 - 04/2018
3	Lasers (Laser) 01/2024 - 01/2016
2	Aftercare (After-Treatment) 11/2023 - 01/2020